Dai-ichi Karkaria Ltd
Incorporated in 1963, Dai-ichi Karkaria Ltd
is in the business of manufacture and sale
of Specialty chemicals[1]
- Market Cap ₹ 189 Cr.
- Current Price ₹ 255
- High / Low ₹ 472 / 219
- Stock P/E
- Book Value ₹ 248
- Dividend Yield 1.37 %
- ROCE -1.01 %
- ROE -0.30 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.03 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.6% over past five years.
- Company has a low return on equity of 0.86% over last 3 years.
- Earnings include an other income of Rs.4.45 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | 194 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 132 | 181 | 161 | |
| 159 | 161 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 167 | 158 | |
| Operating Profit | 22 | 32 | 17 | 15 | -11 | -5 | -14 | -18 | 16 | 6 | 14 | 3 |
| OPM % | 12% | 17% | 14% | 10% | -12% | -5% | -14% | -15% | 9% | 5% | 8% | 2% |
| 15 | 4 | 12 | 6 | 2 | -0 | 87 | 8 | 17 | 24 | 6 | 4 | |
| Interest | 0 | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 | 1 |
| Depreciation | 5 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 | 10 |
| Profit before tax | 32 | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 18 | 8 | -3 |
| Tax % | 28% | 35% | 24% | 27% | -48% | 0% | 13% | 0% | 16% | 27% | 27% | 2% |
| 23 | 22 | 25 | 14 | -13 | -23 | 51 | -18 | 20 | 14 | 9 | -1 | |
| EPS in Rs | 31.24 | 29.34 | 33.43 | 18.32 | -16.92 | -30.76 | 68.02 | -24.20 | 26.94 | 18.65 | 12.11 | -0.99 |
| Dividend Payout % | 10% | 10% | 9% | 14% | -15% | -8% | 4% | 0% | 15% | 11% | 29% | -151% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 11% |
| 3 Years: | -4% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | % |
| TTM: | -107% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -7% |
| 3 Years: | -13% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 101 | 119 | 142 | 151 | 135 | 112 | 163 | 142 | 162 | 173 | 181 | 177 |
| 1 | 1 | 4 | 77 | 104 | 108 | 20 | 22 | 38 | 19 | 13 | 13 | |
| 38 | 31 | 25 | 41 | 35 | 42 | 48 | 43 | 39 | 23 | 31 | 26 | |
| Total Liabilities | 147 | 159 | 179 | 276 | 281 | 270 | 239 | 214 | 247 | 222 | 232 | 224 |
| 16 | 17 | 20 | 94 | 164 | 153 | 105 | 105 | 139 | 132 | 126 | 122 | |
| CWIP | 6 | 14 | 32 | 43 | 5 | 3 | 0 | 2 | 0 | 2 | 1 | 4 |
| Investments | 42 | 40 | 64 | 41 | 24 | 23 | 27 | 21 | 23 | 21 | 24 | 27 |
| 83 | 88 | 62 | 98 | 88 | 92 | 107 | 86 | 85 | 67 | 82 | 71 | |
| Total Assets | 147 | 159 | 179 | 276 | 281 | 270 | 239 | 214 | 247 | 222 | 232 | 224 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 11 | 3 | -8 | 6 | 1 | -22 | -3 | 23 | 10 | 16 | 5 | |
| -0 | -8 | -7 | -57 | -21 | 1 | 130 | -4 | -33 | 16 | -4 | -10 | |
| -3 | -6 | 2 | 66 | 16 | -6 | -97 | -2 | 13 | -25 | -10 | -3 | |
| Net Cash Flow | 3 | -3 | -2 | 2 | 1 | -4 | 11 | -10 | 4 | 1 | 2 | -8 |
| Free Cash Flow | -9 | -0 | -19 | -90 | -32 | -1 | 109 | -14 | -10 | 5 | 14 | -4 |
| CFO/OP | 67% | 71% | 54% | -27% | -60% | -9% | 103% | 18% | 150% | 165% | 111% | 138% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 70 | 59 | 75 | 65 | 70 | 89 | 53 | 53 | 62 | 60 | 71 |
| Inventory Days | 53 | 51 | 78 | 74 | 98 | 104 | 133 | 93 | 59 | 77 | 60 | 68 |
| Days Payable | 94 | 82 | 68 | 83 | 128 | 146 | 210 | 122 | 87 | 74 | 75 | 62 |
| Cash Conversion Cycle | 34 | 39 | 70 | 66 | 36 | 28 | 11 | 24 | 25 | 65 | 45 | 77 |
| Working Capital Days | 43 | 52 | 67 | 54 | -9 | -38 | 27 | 13 | 4 | 21 | 36 | 59 |
| ROCE % | 23% | 28% | 17% | 8% | -7% | -4% | -8% | -12% | 8% | 0% | 4% | -1% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Electricity Consumption per Unit of Production KWH/Ton ・Standalone data |
|
||||||||||
| R&D Intensity (Expenditure as % of Turnover) % ・Standalone data |
|||||||||||
| Annual Segment Growth - Energy & Oil % ・Standalone data |
|||||||||||
| Total Sales Volume Metric Tons (MT) ・Standalone data |
|||||||||||
| Estimated Capacity Utilization (Dahej/General Plant) % ・Standalone data |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Capacity Addition- Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
9 May - Dahej Alkoxylation capacity to expand by 5,000 MT annually; Rs. 10 crore investment by FY26-27.
-
Results Presentation For The Period Ended March 31, 2026
8 May - FY26 results presentation submitted for quarter and year ended March 31, 2026.
-
Corporate Action-Board approves Dividend
8 May - FY26 standalone and consolidated results approved; 15% dividend of Rs.1.50/share recommended, subject to AGM approval.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On May 8, 2026 - Financial Results For The Quarter And Financial Year Ended
March 31, 2026, And Recommendation Of Dividend For The Financial Year Ended March 31, 2026.
8 May - Board approved FY26 audited standalone and consolidated results, recommended Rs.1.50 final dividend.
-
Financial Results For The Quarter And Financial Year Ended
March 31, 2026
8 May - Board approved FY26 audited results on May 8, 2026 and recommended 15% dividend of Rs.1.50 per share.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is ISO 9001 certified and
in the business of development and manufacture of high-performance
specialty chemicals for various
applications. It has technical
collaboration with the Dai-
ichi Kogyo Seiyaku Co.
Ltd, of Japan